Back to News
Market Impact: 0.25

Validea Detailed Fundamental Analysis

CMENDAQ
Company FundamentalsAnalyst InsightsMarket Technicals & FlowsInvestor Sentiment & Positioning
Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates that CME Group Inc. (CME) receives a 68% rating based on their Multi-Factor Investor model, which is derived from the investment strategy of Pim van Vliet focused on low volatility, strong momentum, and high net payout yields; while CME passes tests for market capitalization and standard deviation, it receives a neutral rating for both twelve minus one momentum and net payout yield, ultimately resulting in a "fail" for the final rank within this strategy.

Analysis

CME Group Inc. (CME) fails to meet the investment criteria of Validea's Multi-Factor Investor model, which is based on the strategy of Pim van Vliet. Despite being a large-cap stock in the Investment Services industry, CME scored only 68%, falling short of the 80% threshold that indicates strategic interest. The analysis reveals a mixed fundamental profile under this specific lens: while CME passes on key defensive metrics like market capitalization and low volatility (standard deviation), it demonstrates weakness in the other two core pillars of the strategy. The company received a 'NEUTRAL' rating for both its 'TWELVE MINUS ONE MOMENTUM' and its 'NET PAYOUT YIELD'. This combination of favorable low-risk characteristics with lackluster momentum and shareholder return metrics ultimately results in a 'FAIL' for its final rank, a conclusion supported by the moderately negative sentiment score of -0.5 for the ticker.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately negative

Sentiment Score

-0.40

Ticker Sentiment

CME-0.50
NDAQ0.00

Key Decisions for Investors

  • Investors following quantitative, multi-factor strategies similar to Pim van Vliet's should note CME's 'FAIL' rating, as the stock currently lacks the requisite momentum and net payout yield to warrant inclusion based on this model.
  • For risk-averse investors, CME's confirmed low-volatility profile is a positive attribute, but this must be balanced against the neutral ratings on momentum and yield, which could suggest limited near-term capital appreciation potential.
  • Consider monitoring CME's capital return programs and relative price performance, as a significant improvement in its net payout yield or momentum would be required for the stock to become attractive under this specific factor-based screening methodology.